Inactivation Of Angptl3 And Cardiovascular Disease
3.866
2:21
Aha 25 Crispr-Cas9 Gene Editing Therapy Targeting...
373
3:43
Mechanism Of Action For Angptl3 Inhibitors In Hofh
849
2:07
Advances In Dyslipidaemia Treatments Focusing On...
406
2:02
Unlocking The Potential Of Angptl3 In Dyslipidemia
267
4:06
Genetic And Pharmacological Inactivation Of...
57
2:26
New Antisense Inhibitor Nets Impressive...
92
4:00
Zodasiran, An Rnai Theutic Targeting Angptl3, For...
1:22
Evinaab Angiopoietin-Like Protein 3 Angptl3...
150
2:14
Target Angptl3, Tame The Lipids, Transform The...
37
4:55
Algorithm For Management Of Dyslipidemia - 2025...
46
7:41
Getting Your Cholesterol To Goal The Growing List...
224
12:55
Newer Anti-Lipid Agents Pcsk9 Inhibitors...
242
Angptl3 Angiopoietin Like 3
1
0:20
Aha 2020 Evinaab Safety And Efficacy In Hofh
905
7:44
Angptl3 Results
133
7:33
Four Ways By Which Lipoprotein A Increases...
262
0:51
New Theutic Approaches To The Treatment Of...
591
1:38
Crispr-Cas9 Therapy A Revolutionary Treatment For...
3:39
46. Apo B And Lipoproteins Genzyme
1.887
2:11
Evinaab Mechanism Of Action
496
1:42